Forest Labs says Namenda sales impacted by long term care facility initiatives

On the Q2 conference call. Forest Lab cited initiatives related to the care of Alzheimers patients in long term care facilities have been put in place by certain long term care providers. These initiatives which Forest supports are designed to improve the overall quality of care of Alzheimers patients, as well as reduce the inappropriate use of certain types of medication. Forest Labs believes that these initiatives may have had a temporary unintended effect on the use of approved Alzheimers medication including Namenda and the other inhibitors.

View Comments (0)